FDA approves first pill to help prevent HIV
The Food and Drug Administration has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS.
The agency approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.
Gilead Sciences Inc. has marketed Truvada since 2004 as a treatment for people who are infected with the virus.
But company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure. A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42 percent, when accompanied by condoms and counseling.
AP
More News
- Intel chief: NSA foiled dozens of terrorist plots
- Chrysler agrees to recall of Jeeps at risk of fire
- US, Taliban to start talks on ending Afghan war
- G-8 summit turns focus to clampdown on tax-dodging
- Syrian warplanes strike rebel posts in Aleppo
- Demonstrators flood Brazilian streets in protest
- Lawyer for Gadhafi son wants him handed to ICC
- Investigators 'zeroing in' on Colo. wildfire start
- Greece's public TV still off despite court ruling
- Turkey Could Deploy Army To Quell Protests
